In order to evaluate the potential therapeutic effect of the sigma-2 ligand, SV119, in combination with conventional chemotherapy, we treated pancreatic cancer cell lines with SV119 and the chemotherapeutic agents gemcitabine and paclitaxel. The gene discussed is AP2S1; the disease is pancreatic neoplasm.